IMPACT-MH

Consortium Seminar: Mark Gerstein - Digital Phenotyping from Wearables Using AI
2025-06-09 15:00 - 16:00 (America/New_York)

[DAWG] Karina Pereira-Lima - Target Trial Emulation of Sleep and Physical Activity Interventions for Depression Prevention
2025-05-28 12:30 - 13:30 UTC

Consortium Seminar: Roy Perlis-AI in Psychiatry, from ELIZ A to Evil Robots
2025-05-12 15:00 - 16:00 UTC

IMPACT-MH Monthly Seminar
2025-05-02 15:00 - 16:00 UTC
IMPACT is excited to announce that our next seminar series on Friday, May 2nd at 3:00pm will be presented by Dr. David Epstein. David Epstein received his doctorate in Biopsychology & Behavioral Neuroscience from the Psychology Department at Rutgers University in 1998. Since then, he has conducted human research at the National Institute on Drug Abuse in Baltimore, where he is now a tenure-track investigator. He leads a research group called RAPT: the “Real-world Assessment, Prediction, and Treatment” unit. He has over 20 years of experience in EMA (ecological momentary assessment) in people who use drugs nonmedically. EMA is the focus of most of his publications, which number almost 200 and have been cited over 12,000 times. These publications include the first large-scale deployment of EMA in people who use heroin and cocaine, and more recently the first-ever EMA study of people who use the legal drug kratom. He is preparing a program of studies on boredom and what he calls its opposites (such as curiosity and psychological richness) as risk/protective factors and mobile-intervention targets for people who use cannabis.

Join meeting: https://yale.zoom.us/j/2034150643?omn=95730765502&from=addonMeeting ID: 203 415 0643

April DAWG Presentation
2025-04-30 12:30 - 13:30 UTC

Isaac R. Galatzer-Levy, PhD: Generative Psychometrics
2025-04-14 15:00 - 16:00 UTC

IMPACT-MH Monthly Seminar-A Neurocomputational Framework of Social Connections
2025-03-28 15:00 - 16:00 UTC
IMPACT-MH Is excited to announce that our next monthly seminar series will be presented by Dr. Xiaosi Gu. Dr. Gu is a tenured Associate Professor in the Departments of Psychiatry, Neuroscience, and Artificial Intelligence and Director of the Center for Computational Psychiatry at the Icahn School of Medicine at Mount Sinai in New York City. Her research examines the neural computations underlying higher-order cognition in humans such as reward and social decision-making, using a combination of computational modeling, neuroimaging, and intracranial recording techniques. She is currently leading multiple NIH and private foundation grants to study on how these processes might go awry across various psychiatric disorders, including depression, autism, personality disorders, and drug addiction.

Data Analytics Working Group (DAWG)-Dr. Guillermo Cecchi
2025-03-26 00:30 - 01:30 UTC
Dr. Guillermo Cecchi will be presenting on analyses of patient-doctor interactions, smartphone use patterns and audio diaries, and EHR based clinical information that were done as part of the PREDiCTOR (Phenotypes REimagined to Define Clinical Treatment and Outcome Research) project.

Dr. Godfrey Pearlson: Lessons from the B-SNIP Consortium
2025-03-10 15:00 - 16:00 UTC

IMPACT-MH Monthly Seminar
2025-02-28 15:00 - 16:00 UTC

Feb Deindentification Workshop
2025-02-27 13:00 - 14:30 UTC

De-identification workshop
2025-02-27 13:00 - 14:30 UTC

Meredith L. Wallace, Ph.D.: Large Cohort, Post-Hoc Data Harmonization
2025-02-10 15:00 - 16:00 UTC

IMPACT-MH Monthly Seminar
2025-01-24 15:00 - 16:00 UTC
We will share an introduction to the history and fundamentals of the RDoC framework, with examples from studies that demonstrate how RDoC principles can be applied to a range of mental health questions. We will also discuss key ways in which the framework has evolved since its inception, and how we can benefit from IMPACT-MH’s collective wisdom and data to continue improving approaches to mental health research.

Jenni Pacheco, Ph.D., is a Scientific Program Manager for the Research Domain Criteria (RDoC) Unit at the National Institute of Mental Health (NIMH), and a Program Officer for the Attention Deficit, Disruptive Behaviors, and Disorders of Behavioral Dysregulation Program within the Division of Translational Research.

Becky Berman, Ph.D., is also a Scientific Program Manager for the RDoC Unit at NIMH and serves as Science Officer for the IMPACT-MH U01 projects.
